Evaluate the potential of your pre-launch product in a real-life setting
In traditional TPP research, physicians can overstate the extent to which they are likely to prescribe the proposed product.
Rx Potential uses mobile app technology to test your pre-launch product profile with physicians in both a theoretical and real-life clinical setting to get a truer picture of physician decisions.
Using real patient cases, we assess the situations and patient types in which your product will most likely find initial usage, while also understanding the existing products that it may displace.
- How a real-world methodology was used to understand the potential for a pre-launched product in type 2 diabetes
Our client was developing a new product for treating Type 2 diabetes, which they were preparing for launch. In an increasingly competitive diabetes market, with new brands and formulations frequently becoming available, our client needed to determine the unmet needs of current type 2 diabetes patients and identify where the greatest opportunity lay for their new product.read more »How a mobile methodology elicited a deeper understanding of the key drivers behind physicians’ prescribing decisions
After the recent launch of a competitor drug in cardiology, our client wanted to better understand the degree of differentiation between products, focusing especially on the way physicians justified their selection of specific novel products which are known to be poorly differentiated.read more »Using mobile research to improve our understanding of compliance
Traditional methods of assessing compliance, such as questionnaires, diaries and electronic monitoring systems, have certain limitations and can give biased results. We wanted to investigate if the use of digital techniques could elicit greater insights.read more »
- Rx insights: Harnessing the strengths of mobile research in pharma
Published in PME May 2013 By John Branston, Directorread more »Delivering 'in-the-moment' market research to global healthcare
Published in Research World, October 2012, By John Branston, Director There have been numerous reports in the pharmaceutical and international press concerning the high rate of adoption of mobile devices amongst physicians. A survey conducted earlier this year by Manhattan Research showed that physician use of tablets for professional purposes nearly doubled last year, with 62% of doctors now using the technology. But despite advances…read more »From chaos to calm: how to make sense of social media
What do you know about chaos theory?read more »
John is a Director in the European client service team. He has 17 years experience in healthcare market research, conducting both qualitative and quantitative projects. In 2000, he started to explore and develop the use of the internet as a research tool. John won the Jack Hayhurst Award for best paper at the EphMRA Conference 2012 in Paris for his presentation on mobile research and is pioneering new research approaches using this methodology.